Home  |  Contact Us  
Healthcare Venture Capital and Growth Equity     
Home About Us Our Focus Our Team Portfolio Companies Media Center Limited Partners Contact Us
 
 News and Press
PTV Sciences Announces Three New Venture Partners, Serving as Senior Advisors; Dennis Donohoe, M.D., Marlene Wright Valenti, and Dan Walsh
Julio Palmaz, M.D., Inventor of the World's First Cardiac Stent, is the 2009 Recipient of the PTV Sciences Star of Texas Healthcare Award
Mark McClellan, M.P.A., M.D., Ph.D., Former Commissioner of the Food and Drug Administration, will Serve As Honorary Chair and Keynote Speaker at the PTV Sciences Annual Meeting



PTV Sciences was founded with the belief that an active management style and partnering with entrepreneurs is the path to building great companies with sustainable value. As active investors, our hard work begins when we roll up our sleeves and work in the trenches, side by side with our portfolio companies to ensure success.

PTV Sciences investment strategy is to focus on lower risk opportunities that have a clear “line of sight” to revenue within a short timeframe diversified across sector, stage, and geography. We invest in early to late-stage opportunities with a target to have an appropriate ownership stake in each of our portfolio companies. This structure allows us to make substantial value contributions by leveraging our significant operational capabilities and domain expertise through our collaborative partnership model.

Our ideal investment will be in companies that are built upon “hard science” and will have the following characteristics:

Strong Management
Large and Growing Markets
Novel Ideas
High Operating Margins
Clear Exit Opportunities

 

Home | Site Map | Contact Us
            All rights reserved 2008 PTV Sciences